Table 5

Factors associated with overall response, PFS, and OS

Overall responsePFSOS
Unadjusted [OR (95% CI)]Adjusted [OR (95% CI)]Unadjusted [HR (95% CI)]Adjusted [HR (95% CI)]Unadjusted [HR (95% CI)]Adjusted [HR (95% CI)]
Age (in 10-year increments) 1.16 (0.64-2.11) 1.22 (0.62-2.40) 0.80 (0.59-1.10) 0.72 (0.50-1.04) 0.83 (0.56-1.24) 0.88 (0.51-1.49) 
Number of prior therapies (≥5 vs <5) 1.23 (0.47-3.21) 1.77 (0.56-5.60) 0.79 (0.47-1.33) 0.54 (0.29-0.99)* 0.94 (0.48-1.85) 0.66 (0.32-1.38) 
B2-microglobulin (mg/L) 1.03 (0.84-1.25) 0.99 (0.80-1.23) 1.09 (0.99-1.20) 1.15 (1.03-1.28)* 1.30 (1.15-1.47)* 1.38 (1.21-1.58)* 
High-risk cytogenetics 0.36 (0.11-1.22) 0.33 (0.09-1.22) 1.73 (0.92-3.27) 1.77 (0.88-3.55) 2.12 (1.00-4.48) 2.21 (0.98-4.98) 
Study arm* (arm C vs B) 2.88 (1.09-7.61)* 2.98 (0.99-8.99) 0.66 (0.40-1.10) 0.54 (0.29-1.00)* 0.63 (0.32-1.22) 0.54 (0.25-1.17) 
Overall responsePFSOS
Unadjusted [OR (95% CI)]Adjusted [OR (95% CI)]Unadjusted [HR (95% CI)]Adjusted [HR (95% CI)]Unadjusted [HR (95% CI)]Adjusted [HR (95% CI)]
Age (in 10-year increments) 1.16 (0.64-2.11) 1.22 (0.62-2.40) 0.80 (0.59-1.10) 0.72 (0.50-1.04) 0.83 (0.56-1.24) 0.88 (0.51-1.49) 
Number of prior therapies (≥5 vs <5) 1.23 (0.47-3.21) 1.77 (0.56-5.60) 0.79 (0.47-1.33) 0.54 (0.29-0.99)* 0.94 (0.48-1.85) 0.66 (0.32-1.38) 
B2-microglobulin (mg/L) 1.03 (0.84-1.25) 0.99 (0.80-1.23) 1.09 (0.99-1.20) 1.15 (1.03-1.28)* 1.30 (1.15-1.47)* 1.38 (1.21-1.58)* 
High-risk cytogenetics 0.36 (0.11-1.22) 0.33 (0.09-1.22) 1.73 (0.92-3.27) 1.77 (0.88-3.55) 2.12 (1.00-4.48) 2.21 (0.98-4.98) 
Study arm* (arm C vs B) 2.88 (1.09-7.61)* 2.98 (0.99-8.99) 0.66 (0.40-1.10) 0.54 (0.29-1.00)* 0.63 (0.32-1.22) 0.54 (0.25-1.17) 

HR, hazard ratio; OR, odds ratio.

Overall response is defined as partial response or better; study arm P = .052 in the multivariable overall response model. *P < .05.

or Create an Account

Close Modal
Close Modal